Pharmacology for Nurses · Ophthalmic Drugs
Antiglaucoma Drugs
On this page 9 sections
In 30 seconds
Glaucoma is a group of eye diseases that damage the optic nerve — the cable carrying visual information from the eye to the brain — and a leading cause of irreversible blindness worldwide. Elevated Intraocular pressure (IOP) The fluid pressure inside the eye is its most important modifiable risk factor, and antiglaucoma drugs lower pressure by either decreasing Aqueous humor The clear fluid produced by the ciliary body filling the front of the eye Full entry → production (the fluid filling the front of the eye) or increasing its drainage. Major classes include beta blockers, alpha-2 adrenergic agonists, carbonic anhydrase inhibitors, prostaglandin analogs, miotics, and rho kinase inhibitors, plus combination products pairing two mechanisms. Because glaucoma is chronic, these drugs are usually taken for life — making adherence and correct instillation core nursing concerns. This page is an educational study guide: classes and mechanisms only, with no doses or treatment recommendations — verify specifics against current references, the formulary, and prescriber orders.
Why this matters
Vision loss from glaucoma can't be reversed, but it can often be slowed or prevented when pressure is controlled. The everyday nursing work — teaching correct instillation, confirming the person can get the drop in, supporting years of adherence — is genuinely vision-saving. These drops also teach a classic lesson: eye drops can be absorbed systemically through nasolacrimal drainage, so a "local" drop can have whole-body effects. And the mechanism variety is exam gold: knowing how each class works lets you predict effects and side effects.
The college version
Core Concepts
Aqueous humor: production and drainage
The ciliary body produces aqueous humor, which circulates through the pupil and leaves by two routes: mainly through the Trabecular meshwork The spongy filter at the eye's drainage angle Full entry →, a spongy filter at the drainage angle, and secondarily through the Uveoscleral pathway A secondary fluid-drainage route past the ciliary muscle and sclera Full entry → past the ciliary muscle and sclera. IOP rises when production outpaces drainage, so drugs either slow the faucet (reduce production) or open the drain (increase outflow). Open-angle glaucoma — the common chronic form — is treated with drops doing either; angle-closure glaucoma is an acute emergency (a red, painful eye with halos, nausea, and blurred vision needs immediate evaluation per institutional policy) and is outside this page's scope.
Classes that reduce aqueous humor production
Beta blockers (e.g., timolol) block beta receptors on the ciliary body, decreasing aqueous production; because some of the drop is absorbed systemically, they can produce systemic beta blockade — an assessment flag for asthma-type conditions, slow heart rates, or heart-conduction problems. Alpha-2 adrenergic agonists (e.g., brimonidine) also reduce production and may increase uveoscleral outflow; they can cause local allergy-like reactions and, when absorbed, dry mouth, fatigue, or blood-pressure changes. Carbonic anhydrase inhibitors (e.g., dorzolamide, brinzolamide) reduce production by inhibiting carbonic anhydrase in the ciliary body; because this enzyme family relates to sulfonamide chemistry, sulfonamide allergy histories may need careful assessment — verify with current references.
Classes that increase aqueous humor outflow
Prostaglandin analogs (e.g., latanoprost) increase uveoscleral outflow and are often first-line with once-daily convenience. Their distinctive side effects are local: gradual iris darkening, eyelash thickening, conjunctival redness, eye-socket changes — mostly cosmetic but worth warning patients about. Miotics (cholinergic agonists such as pilocarpine) increase trabecular outflow by contracting the ciliary muscle, which also constricts the pupil; side effects include dimmed vision and brow ache. Rho kinase inhibitors (e.g., netarsudil) are newer, increasing trabecular outflow; they can cause redness and corneal effects and are used in specific situations. Combination products pair mechanisms (e.g., a beta blocker plus a Prostaglandin analog A drug increasing uveoscleral outflow Full entry →) for convenience and adherence — fewer bottles, fewer instillations.
Administration and nursing considerations
Teach and verify instillation: hand hygiene; one drop into the lower lid pocket; tip never touching the eye; and Punctal occlusion Pressing the inner eye corner after instilling Full entry → — pressing the inner corner of the eye after instilling — which limits drainage to the nose and throat and systemic absorption. Space different drops several minutes apart. If the person can't manage drops, discuss options with the care team per institutional policy. Monitor for blurred vision, eye pain, redness, or vision changes, reporting promptly; systemic effects (heart rate, breathing, energy) should also be reported. Glaucoma therapy is lifelong: assess adherence openly and non-judgmentally and involve family or caregivers as the person wishes. Scope of practice for instillation and teaching varies by jurisdiction and institution.
Common Confusions
| Do Not Confuse | With | Difference |
|---|---|---|
| Glaucoma | Simply "high eye pressure" | Glaucoma is defined by optic nerve damage; IOP is the main risk factor |
| All glaucoma drops working the same way | Mechanism-specific classes | Some reduce production, others increase outflow — mechanisms predict side effects |
| Miotics (pupil-constricting) | Drops that dilate the pupil | Miotics constrict; dilation drops are for exams — classic test trap |
| Cosmetic prostaglandin changes | An allergic reaction | Iris darkening, lash growth, redness are expected; allergy involves swelling, itching, or breathing symptoms |
| Systemic absorption being negligible | Drops staying in the eye | Tears drain to the nose/throat, so some of every drop is absorbed — the basis for punctal occlusion |
| One-time treatment | Lifelong therapy | Stopping lets pressure rise again; therapy protects remaining vision |
Eli explains
The same idea, in plain words
Explain it like I’m 10
Your eye makes a clear fluid that keeps it shaped and fed, and that fluid needs a drain — like water in a sink. In glaucoma the drain clogs or the faucet runs too fast, pressure builds, and over time it hurts the optic nerve — the eye's cable to the brain. Glaucoma drops work like a plumber: some turn down the faucet so less fluid is made, and others unclog the drain so more fluid flows out. The drops keep pressure down, but only while they're used — so people with glaucoma take them daily for years.
Worked example
Ms. Okafor, 62, is newly diagnosed with open-angle glaucoma. Her provider starts a prostaglandin analog — one instillation daily — and the teaching lands in the nurse's lap. The nurse watches her demonstrate with a practice bottle: head tilted back, lower lid pulled down, tip almost touching her lashes — and coaches her to keep the tip clear and press the inner eye corner afterward. The nurse explains the why: the drop opens the fluid drain, pressure will be checked at follow-up, and the medicine only protects vision while she keeps taking it. She is warned that the eye may look red and the iris may darken or lashes thicken — expected cosmetic changes, not allergy — but eye pain, sudden vision loss, or new floaters should be reported promptly. Before she leaves, the nurse helps her choose a daily reminder strategy. Six weeks later her IOP has improved and she has not missed a dose — the teaching met her where she was.
Key takeaways
- Glaucoma = optic nerve damage; elevated IOP is the main modifiable risk factor — vision loss is irreversible, so preventing progression is the goal.
- Two strategies: reduce aqueous production OR increase outflow (trabecular or uveoscleral).
- Production reducers: beta blockers, alpha-2 agonists, carbonic anhydrase inhibitors.
- Outflow increasers: prostaglandin analogs (uveoscleral); miotics and rho kinase inhibitors (trabecular).
- Prostaglandin analogs are often first-line: once-daily, with cosmetic changes — iris color, lashes, redness, eye socket.
- Topical drops are absorbed systemically — assess beyond the eye (heart, lungs, blood pressure).
- Punctal occlusion reduces systemic absorption — a key teaching point.
- Red, painful eye with halos/nausea/blurred vision suggests acute angle closure — an emergency needing immediate evaluation.
- Adherence is everything: lifelong therapy only protects vision while used.
- Verify against current references, the formulary, and prescriber orders.
Check yourself
6 review questions from the chapter. Try each one, then open the answer.
What are the two broad mechanisms by which antiglaucoma drugs lower IOP?
Show answer
Reducing aqueous humor production (beta blockers, alpha-2 agonists, carbonic anhydrase inhibitors) and increasing outflow (prostaglandin analogs via uveoscleral; miotics and rho kinase inhibitors via trabecular).
Which classes reduce aqueous production, and which increase outflow?
Show answer
Production reducers: beta blockers, alpha-2 agonists, CAIs. Outflow increasers: prostaglandin analogs, miotics, rho kinase inhibitors.
Why are prostaglandin analogs distinctive among antiglaucoma classes?
Show answer
They increase uveoscleral outflow, are often once-daily first-line, and have distinctive local effects — iris darkening, lash growth, redness — to warn patients about.
What is punctal occlusion, and why is it taught?
Show answer
Pressing the inner eye corner after instillation; it blocks nasolacrimal drainage, reducing systemic absorption.
A patient's eye looks red after starting a new glaucoma drop. Is that automatically an emergency?
Show answer
No — redness is an expected prostaglandin effect. But eye pain, sudden vision loss, new floaters, swelling, or breathing symptoms warrant prompt reporting.
Why does topical glaucoma therapy require assessment of the heart and lungs?
Show answer
Because a portion of every topical drop is absorbed systemically; ocular beta blockers can produce systemic beta blockade, so heart and lung status is assessed.
Study tools & related lessonsKey vocabulary · Related
Key vocabulary
- Intraocular pressure (IOP)
- The fluid pressure inside the eye
- Aqueous humor
- The clear fluid produced by the ciliary body filling the front of the eye
- Trabecular meshwork
- The spongy filter at the eye's drainage angle
- Uveoscleral pathway
- A secondary fluid-drainage route past the ciliary muscle and sclera
- Beta blocker (ocular)
- A drug blocking beta receptors on the ciliary body, reducing aqueous production
- Prostaglandin analog
- A drug increasing uveoscleral outflow
- Punctal occlusion
- Pressing the inner eye corner after instilling
- Miotic
- A drug that constricts the pupil by contracting the ciliary muscle
Sources & references
This lesson was adapted from the open educational references above; their licenses and attributions are preserved. See Copyright & Licensing.
Educational content only. It is not medical, legal or professional advice. Found an error? Tell us.